Cargando…

Programmed Cell Death Ligand 1 Expression on Immune Cells and Survival in Patients With Nonmetastatic Head and Neck Cancer: A Systematic Review and Meta-analysis

IMPORTANCE: The failure or success of radical treatment in patients with head and neck squamous cell carcinoma (HNSCC) is associated with many known and unknown factors; hence, there is a search for further prognostic markers to help optimize therapeutic strategy and improve treatment outcomes. OBJE...

Descripción completa

Detalles Bibliográficos
Autores principales:	Blažek, Tomáš, Petráš, Marek, Knybel, Lukáš, Cvek, Jakub, Soumarová, Renata
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2023
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10066461/ https://www.ncbi.nlm.nih.gov/pubmed/37000447 http://dx.doi.org/10.1001/jamanetworkopen.2023.6324

Ejemplares similares

Dose escalation in advanced floor of the mouth cancer: a pilot study using a combination of IMRT and stereotactic boost
por: Blažek, Tomáš, et al.
Publicado: (2021)

Prostate deformation during hypofractionated radiotherapy: an analysis of implanted fiducial marker displacement
por: Knybel, Lukas, et al.
Publicado: (2021)

FMISO-Based Adaptive Radiotherapy in Head and Neck Cancer
por: Dolezel, Martin, et al.
Publicado: (2022)

Repeated stereotactic radiotherapy of recurrent ventricular tachycardia
por: Cvek, Jakub, et al.
Publicado: (2023)

Radiochemotherapy in stage III/IV nonmetastatic squamous cell head and neck cancer
por: Schäfer, C, et al.
Publicado: (2006)

Association Between Spatial Heterogeneity Within Nonmetastatic Gastroesophageal Adenocarcinomas and Survival
por: Chao, Joseph, et al.
Publicado: (2020)

Stereotactic radiotherapy for spinal hemangioblastoma – disease control and volume analysis in long-term follow up
por: Cvek, Jakub, et al.
Publicado: (2022)

Stereotactic Ablative Radiotherapy of Ventricular Tachycardia Using Tracking: Optimized Target Definition Workflow
por: Dvorak, Pavel, et al.
Publicado: (2022)

Neighborhood and Individual Socioeconomic Disadvantage and Survival Among Patients With Nonmetastatic Common Cancers
por: Cheng, En, et al.
Publicado: (2021)

Survival Outcomes by Race and Ethnicity in Veterans With Nonmetastatic Castration-Resistant Prostate Cancer
por: Rasmussen, Kelli M., et al.
Publicado: (2023)

Real-time measurement of ICD lead motion during stereotactic body radiotherapy of ventricular tachycardia
por: Knybel, Lukas, et al.
Publicado: (2021)

Case Report: Repeated Stereotactic Radiotherapy of Recurrent Ventricular Tachycardia: Reasons, Feasibility, and Safety
por: Haskova, Jana, et al.
Publicado: (2022)

Significance of delayed primary excision in localized nonmetastatic adult head and neck rhabdomyosarcoma
por: Kobayashi, Kenya, et al.
Publicado: (2016)

HPV and RAD51 as Prognostic Factors for Survival in Inoperable Oral and Oropharyngeal Cancer in Patients Unfit for Chemotherapy Treated with Hyperfractionated Radiotherapy
por: Zděblová Čermáková, Zuzana, et al.
Publicado: (2023)

Inflammation and fibrosis characterize different stages of myocardial remodeling in patients after stereotactic body radiotherapy of ventricular myocardium for recurrent ventricular tachycardia
por: Kučera, Tomáš, et al.
Publicado: (2023)

Development of a Nomogram Model for Treatment of Nonmetastatic Nasopharyngeal Carcinoma
por: Zhang, Lu-Lu, et al.
Publicado: (2020)

The analysis of respiration-induced pancreatic tumor motion based on reference measurement
por: Knybel, Lukas, et al.
Publicado: (2014)

Survival of Patients With Head and Neck Merkel Cell Cancer: Findings From the Pan-Canadian Merkel Cell Cancer Collaborative
por: Nayak, Ameeta Lubina, et al.
Publicado: (2023)

Chronic refractory angina pectoris treated by bilateral stereotactic radiosurgical stellate ganglion ablation: first-in-man case report
por: Hudec, Miroslav, et al.
Publicado: (2021)

Association Between Obesity and Histological Tumor Budding in Patients With Nonmetastatic Colon Cancer
por: Gan, Tong, et al.
Publicado: (2021)

Dermoscopic and clinical features of head and neck melanoma
por: Cengiz, Fatma Pelin, et al.
Publicado: (2015)

Glycoprotein Nonmetastatic Melanoma Protein B as Potential Imaging Marker in Posttherapeutic Metastatic Head and Neck Cancer
por: van Schaik, Jeroen E., et al.
Publicado: (2020)

Chromoendoscopy to Detect Early Synchronous Second Primary Esophageal Carcinoma in Patients with Squamous Cell Carcinomas of the Head and Neck?
por: Komínek, Pavel, et al.
Publicado: (2013)

Association of Nonsteroidal Anti-inflammatory Drug Use With Survival in Patients With Squamous Cell Carcinoma of the Head and Neck Treated With Chemoradiation Therapy
por: Iovoli, Austin J., et al.
Publicado: (2020)

Toxicity Profiles and Survival Outcomes Among Patients With Nonmetastatic Nasopharyngeal Carcinoma Treated With Intensity-Modulated Proton Therapy vs Intensity-Modulated Radiation Therapy
por: Li, Xingzhe, et al.
Publicado: (2021)

Toxicity Profiles and Survival Outcomes Among Patients With Nonmetastatic Oropharyngeal Carcinoma Treated With Intensity-Modulated Proton Therapy vs Intensity-Modulated Radiation Therapy
por: Youssef, Irini, et al.
Publicado: (2022)

Association of Molecular Subtypes With Differential Outcome to Apalutamide Treatment in Nonmetastatic Castration-Resistant Prostate Cancer
por: Feng, Felix Y., et al.
Publicado: (2021)

Invasive head and neck cutaneous squamous cell carcinoma: clinical and histopathological characteristics, frequency of local recurrence and metastasis()
por: Vasconcelos, Luiza, et al.
Publicado: (2014)

Association of Type of Treatment Facility With Overall Survival After a Diagnosis of Head and Neck Cancer
por: Carey, Ryan M., et al.
Publicado: (2020)

Surgery and adjuvant radiotherapy vs concurrent chemoradiotherapy in stage III/IV nonmetastatic squamous cell head and neck cancer: a randomised comparison
por: Soo, K-C, et al.
Publicado: (2005)

Factors Modifying the Associations of Single or Combination Programmed Cell Death 1 and Programmed Cell Death Ligand 1 Inhibitor Therapies With Survival Outcomes in Patients With Metastatic Clear Cell Renal Cell Carcinoma: A Systematic Review and Meta-analysis
por: Sati, Neha, et al.
Publicado: (2021)

Evaluation of Proton Therapy Reirradiation for Patients With Recurrent Head and Neck Squamous Cell Carcinoma
por: Lee, Anna, et al.
Publicado: (2023)

Evaluation of Programmed Death - Ligand 1 (Pd-L1) Expression in Head and Neck Squamous Cell Carcinoma
por: Unnikrishnan, Aarya, et al.
Publicado: (2023)

Disparities in survival by stage after surgery between pancreatic head and body/tail in patients with nonmetastatic pancreatic cancer
por: Zheng, Zhenjiang, et al.
Publicado: (2019)

The Global Otolaryngology–Head and Neck Surgery Workforce
por: Petrucci, Beatriz, et al.
Publicado: (2023)

Evaluation of Hypofractionated Radiation Therapy Use and Patient-Reported Outcomes in Men With Nonmetastatic Prostate Cancer in Australia and New Zealand
por: Pryor, David I., et al.
Publicado: (2021)

Evaluation of Optimal Threshold of Neutrophil-Lymphocyte Ratio and Its Association With Survival Outcomes Among Patients With Head and Neck Cancer
por: Ma, Sung Jun, et al.
Publicado: (2022)

Association of Pack-Years of Cigarette Smoking With Survival and Tumor Progression Among Patients Treated With Chemoradiation for Head and Neck Cancer
por: Ma, Sung Jun, et al.
Publicado: (2022)

Prognostic and predictive role of soluble programmed death ligand-1 in head and neck cancer
por: Molga-Magusiak, Maria, et al.
Publicado: (2023)

Programmed Cell Death-Ligand 1 in Head and Neck Squamous Cell Carcinoma: Molecular Insights, Preclinical and Clinical Data, and Therapies
por: Meliante, Piero Giuseppe, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ssj2hmioe194sk4s44irjbd81f